SABBY MANAGEMENT LLC 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-03 3:54 pm Sale |
2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 60,325 4.900% |
-12,152 (-16.77%) |
Filing |
| 2024-01-03 4:59 pm Purchase |
2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO |
SABBY MANAGEMENT LLC | 72,477 11.000% |
72,477 (New Position) |
Filing |